AmgenFRA:AMG +2.20%87 OCF Yield % is 5.56 as of Jun. 29, 2026, which is 26% below its 10-year median of 7.50. GuruFocus rates FRA:AMG with a GF Score™ of 87/100 and a GF Value™ of €308.97 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,002 Drug Manufacturers companies, Amgen ranks better than 61.78% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Amgen OCF Yield % Related Terms
Amgen OCF Yield % Historical Data
* Premium members only.
The historical data trend for Amgen's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Amgen's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amgen's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Amgen's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amgen (FRA:AMG) has a OCF Yield % of 5.56 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Amgen and its competitors. This is 26% below median its historical median of 7.50. Over the past decade, Amgen's OCF Yield % has ranged from 3.53 to 9.98. According to the industry distribution chart, Amgen ranks #383 out of 1002 companies in the Drug Manufacturers industry, placing it in the top 38.2%.
Is Amgen's OCF Yield % too high?
Amgen's current OCF Yield % of 5.56 is 26% below median its 10-year median of 7.50. Over the past 10 years, this metric has ranged from a low of 3.53 to a high of 9.98. The Drug Manufacturers industry median OCF Yield % is 3.61. Amgen's value of 5.56 is 54% above this industry median. Based on the distribution chart, Amgen ranks #383 out of 1002 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Amgen has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Amgen's OCF Yield % compare to GILD and PFE?
According to the Drug Manufacturers industry distribution chart, Amgen ranks #383 out of 1002 companies for OCF Yield %. This puts Amgen in the upper half of its industry. The industry median OCF Yield % is 3.61. Amgen's value of 5.56 is 54% above this benchmark. Historically, Amgen's own OCF Yield % has ranged from 3.53 to 9.98 over the past decade. While the company's 10-year median is 7.50 vs. the industry median of 3.61, Amgen has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amgen's current OCF Yield % of 5.56 is 54% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Amgen and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amgen's current OCF Yield % is 5.56, which is 26% below median its own 10-year median of 7.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amgen stock overvalued right now?
Based on GuruFocus' analysis, Amgen (FRA:AMG) is currently considered Fairly Valued. The stock's GF Value™ is €308.97, compared to a current price of €313.15 — trading 1.4% above its estimated fair value. The current OCF Yield % is 5.56, which is 26% below median its 10-year median of 7.50 and 54% above the Drug Manufacturers industry median of 3.61. Amgen's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Amgen (FRA:AMG), the current OCF Yield % is 5.56 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amgen (FRA:AMG) Overvalued in 2026?
Based on GuruFocus' analysis, Amgen stock appears to be overvalued.
The current stock price of €313.15 is trading 1.4% above its estimated GF Value™ of €308.97.
GuruFocus considers Amgen to be Fairly Valued.
Key valuation signals for FRA:AMG:
OCF Yield %: 5.56 (26% below median its 10-year median of 7.50)
GF Value™: €308.97 vs. price of €313.15 (1.4% above fair value)
Industry Position: 54% above the Drug Manufacturers median (#383 of 1002)
No single metric tells the full story. See the FRA:AMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
87GF Score
Get the complete analysis for FRA:AMG
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AMG has been successfully added to your 
